BioMed Research International

BioMed Research International / 2019 / Article

Retraction | Open Access

Volume 2019 |Article ID 4217864 | https://doi.org/10.1155/2019/4217864

BioMed Research International, "Retracted: Treatment of Acute Pulmonary Embolism: Update on Newer Pharmacologic and Interventional Strategies", BioMed Research International, vol. 2019, Article ID 4217864, 2 pages, 2019. https://doi.org/10.1155/2019/4217864

Retracted: Treatment of Acute Pulmonary Embolism: Update on Newer Pharmacologic and Interventional Strategies

Received16 Jul 2019
Accepted16 Jul 2019
Published22 Aug 2019

BioMed Research International has retracted the article titled “Treatment of Acute Pulmonary Embolism: Update on Newer Pharmacologic and Interventional Strategies” [1]. The article was found to contain a substantial amount of material, without citation, from previously published articles, including the following sources:(i)William T. Kuo. “Endovascular Therapy for Acute Pulmonary Embolism”, Journal of Vascular and Interventional Radiology, 2012. https://doi.org/10.1016/j.jvir.2011.10.012. [2](ii)Peter H. Lin, Huiting Chen, Carlos F. Bechara, and Panagiotis Kougias. “Endovascular Interventions for Acute Pulmonary Embolism”, Perspectives in Vascular Surgery and Endovascular Therapy, 2010. (http://journals.sagepub.com/doi/10.1177/1531003510379880). [3](iii)Mitchell J. Daley, and Ishaq Lat. “Clinical Controversies in Thrombolytic Therapy for the Management of Acute Pulmonary Embolism”, Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, 2012. https://doi.org/10.1002/PHAR.1051. [4](iv)Michael R. Jaff, M. Sean McMurtry, Stephen L. Archer, Mary Cushman, Neil Goldenberg, Samuel Z. Goldhaber, J. Stephen Jenkins, Jeffrey A. Kline, Andrew D. Michaels, Patricia Thistlethwaite, Suresh Vedantham, R. James White, Brenda K. Zierler, and on behalf of the American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation, Council on Peripheral Vascular Disease, and Council on Arteriosclerosis, Thrombosis and Vascular Biology, “Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association”, Circulation, vol. 123, no. 16. (https://www.ahajournals.org/doi/full/10.1161/CIR.0b013e318214914f) https://doi.org/10.1161/CIR.0b013e318214914f. [5](v)David F. Allie, Chris J. Hebert, Raghotham R. Patlotla, Agostino Ingraldi, and Craig M. Walker: “Contrast-Induced Nephropathy & Targeted Renal Therapy During Peripheral Vascular Interventions: Results of the Louisiana Targeted Renal Therapy in Critical Limb Ischemia (TRT-CLI) Registry”, American Journal of Cardiology, Volume 104, Issue 6, p. 198D, article TCT-535. https://doi.org/10.1016/j.amjcard.2009.08.571. [6]

References

  1. F. Pelliccia, M. Schiariti, C. Terzano et al., “Treatment of acute pulmonary embolism: update on newer pharmacologic and interventional strategies,” BioMed Research International, vol. 2014, Article ID 410341, 6 pages, 2014. View at: Publisher Site | Google Scholar
  2. W. T. Kuo, “Endovascular therapy for acute pulmonary embolism,” Journal of Vascular and Interventional Radiology, vol. 23, no. 2, pp. 167.e4–179.e4, 2012. View at: Google Scholar
  3. P. H. Lin, H. Chen, C. F. Bechara, and P. Kougias, “Endovascular interventions for acute pulmonary embolism,” Perspectives in Vascular Surgery and Endovascular Therapy, vol. 22, no. 3, pp. 171–182, 2010. View at: Publisher Site | Google Scholar
  4. M. J. Daley and I. Lat, “Clinical controversies in thrombolytic therapy for the management of acute pulmonary embolism,” Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, vol. 32, no. 2, pp. 158–172, 2012. View at: Publisher Site | Google Scholar
  5. M. R. Jaff, M. S. McMurtry, S. L. Archer et al., “Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the american heart association,” Circulation, vol. 123, no. 16, pp. 1788–1830, 2011. View at: Publisher Site | Google Scholar
  6. D. F. Allie, C. J. Hebert, R. R. Patlotla, A. Ingraldi, and C. M. Walker, “Contrast-induced nephropathy & targeted renal therapy during peripheral vascular interventions: results of the louisiana targeted renal therapy in critical limb ischemia (TRT-CLI) registry,” American Journal of Cardiology, vol. 104, no. 6, p. 198D, article TCT-535, 2009. View at: Google Scholar

Copyright © 2019 BioMed Research International. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views837
Downloads321
Citations

Related articles